| 1 |
33626480 | Familial hypercholesterolemia: Is there a role for PCSK9 and thrombin generation? | 2021 Apr |
1 |
| 2 |
33885177 | PCSK9 genetic (rs11591147) and epigenetic (DNA methylation) modifications associated with PCSK9 expression and serum proteins in CAD patients. | 2021 Aug |
1 |
| 3 |
34270402 | Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels Predict Future Cardiovascular Event Risks in Hemodialyzed Black African Patients. | 2021 Jul 20 |
3 |
| 4 |
34341098 | Protective lipid-lowering variants in healthy older individuals without coronary heart disease. | 2021 Jul |
1 |
| 5 |
34627693 | Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units. | 2021 Nov 29 |
1 |
| 6 |
34754882 | A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia. | 2021 |
1 |
| 7 |
32349585 | Correlation between plasma proprotein convertase subtilisin/kexin type 9 and blood lipids in patients with newly diagnosed primary nephrotic syndrome. | 2020 Nov |
2 |
| 8 |
32386000 | [Effect of proprotein convertase subtilisin/kexin type 9 inhibitor on blood lipid profile in patients with extremely high risk atherosclerotic cardiovascular disease]. | 2020 Mar |
1 |
| 9 |
32998342 | PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma. | 2020 Sep 28 |
1 |
| 10 |
33193594 | Candidate Gene Analysis Reveals Strong Association of CETP Variants With High Density Lipoprotein Cholesterol and PCSK9 Variants With Low Density Lipoprotein Cholesterol in Ghanaian Adults: An AWI-Gen Sub-Study. | 2020 |
1 |
| 11 |
30270088 | Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia. | 2018 Oct |
1 |
| 12 |
27531965 | A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels. | 2017 Apr |
1 |
| 13 |
28870033 | [The expression and clinical significance of proprotein convertase subtilisin kexin 9 in rheumatoid arthritis]. | 2017 Sep 1 |
2 |
| 14 |
28994502 | Pro-protein subtilisin kexin-9 (PCSK9) inhibition in practice: lipid clinic experience in 2 contrasting UK centres. | 2017 Nov |
1 |
| 15 |
29296222 | Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9. | 2017 Dec 8 |
1 |
| 16 |
27374222 | Dietary high oleic canola oil supplemented with docosahexaenoic acid attenuates plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels in participants with cardiovascular disease risk: A randomized control trial. | 2016 Dec |
1 |
| 17 |
27494723 | Therapeutic efficacy of PCSK9 monoclonal antibodies in statin-nonresponsive patients with hypercholesterolemia and dyslipidemia: A systematic review and meta-analysis. | 2016 Nov 1 |
1 |
| 18 |
25466598 | ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9. | 2015 Apr |
2 |
| 19 |
25899039 | Combined PCSK9 and APOE polymorphisms are genetic risk factors associated with elevated plasma lipid levels in a Thai population. | 2015 Jun |
2 |
| 20 |
24529132 | Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels. | 2014 Mar |
1 |
| 21 |
25014035 | Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation. | 2014 Sep |
2 |
| 22 |
23329883 | Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels. | 2013 |
2 |
| 23 |
23862071 | Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood. | 2013 |
2 |
| 24 |
21920719 | Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. | 2012 Oct |
1 |
| 25 |
21692990 | Affinity and kinetics of proprotein convertase subtilisin/kexin type 9 binding to low-density lipoprotein receptors on HepG2 cells. | 2011 Aug |
9 |
| 26 |
20525997 | High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol. | 2010 Sep |
1 |
| 27 |
17645871 | Plasma PCSK9 levels correlate with cholesterol in men but not in women. | 2007 Sep 21 |
1 |
| 28 |
14727156 | Genetic variants in PCSK9 affect the cholesterol level in Japanese. | 2004 |
1 |